Erica L. Mann

Erica L. Mann has been a member of the Bayer HealthCare Executive Committee and responsible for the Consumer Care Division since mid-March 2011.

Erica L. Mann was born in Vereeniging, South Africa. She holds an undergraduate degree in Analytical Chemistry and a Marketing Management Diploma from the Institute of Marketing Management, Johannesburg, South Africa.

She began her career in the pharmaceutical industry in 1982 at Eli Lilly & Company in South Africa as a medical representative. This was followed by positions in Marketing at Johnson & Johnson and Lederle Laboratories. In 1992 she was appointed as Head of the Lederle Pharmaceutical Business in South Africa and in 1994, Mann transferred to Wyeth as Managing Director for South Africa and Sub-Equatorial Africa. She then held positions of increasing responsibility at the company through 2009. In 2003, she was appointed Managing Director of the Wyeth Australia and New Zealand Affiliate, where she introduced a range of significant medicines and nutritionals. In April 2009 she assumed the role of Senior Vice President for Wyeth’s Global Nutritional Business and in October 2009 she moved to the United States to join Pfizer upon its acquisition of Wyeth where she was most recently President and General Manager for the Nutrition Division and a member of Pfizer’s Senior Management Team.


Erica L. Mann has held executive positions in several industry organizations, including the South African Pharmaceutical Manufacturers’ Association (PMA) and Medicines Australia, as well as the International Association of Infant Food Manufacturers. She currently is a board member of the World Self Medication Industry Association.

Erica Mann has two adult children.